logo
  

CureVac Appoints Malte Greune As COO

CureVac N.V. (CVAC) said that it has appointed Malte Greune as Chief Operating Officer effective July 1, 2021.

Greune joins CureVac from Sanofi-Aventis Deutschland GmbH where he held various management positions for almost ten years. Prior to his position as Head of Diabetes, Oncology and Devices at Sanofi, he worked as Senior Vice President of Animal Health Manufacturing for the Merck Manufacturing Division, USA, where he led an international network of 28 sites - including 18 integrated vaccine sites.

CureVac also announced that Florian von der Mülbe, co-founder and Chief Production Officer, will now focus his extensive production expertise exclusively on the expansion and accelerated development of The RNA Printer, CureVac's solution for mobile, autonomous and fully automated manufacturing of GMP-grade RNA vaccines and therapeutics.

von der Mülbe will resign from the Management Board of CureVac N.V. Greune will assume von der Mülbe's position on the Management Board.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Salt Lake City, Utah-based Huish Outdoors is recalling Oceanic Adult Dry Top Snorkels sold exclusively at Costco citing risk for drowning, U.S. Consumer Product Safety Commission said. The recall involves about 76,000 units of Oceanic Adult Dry Top Snorkels. The recall was initiated after Oceanic received 13 reports of the snorkels leaking. Boeing expects Europe's commercial aviation fleet to need 8,705 new airplanes through 2040 to cater to the growing leisure travel market in the region and fleet replacements with more fuel-efficient models, according to the Boeing's 2021 Commercial Market Outlook (CMO), an annual forecast of long-term demand for commercial airplanes and services. The U.S. Food and Drug Administration authorized marketing of a software developed by Paige.AI, a provider of AI-based digital diagnostics, which could help pathologists to identify prostate cancer. The software, called Paige Prostate, is the first and only artificial intelligence or AI-based pathology product to receive FDA approval for in vitro diagnostic or IVD use in detecting cancer...
Follow RTT